Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-061355

Clearside Biomedical, Inc. · CLSD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Clay Thorp
Director · 10% Owner
Period of report
Dec 6, 2018
Accepted (ET)
Dec 6, 2018 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 6, 2018P8,000$1.36A8,000D
Common StockF2,F3holding———3,466,394ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses